An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations

03/03/2016
02/07/2024
EU PAS number:
EUPAS12598
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

D3820R00006 CSP - PRAC 01212015 final

English (331.4 KB - PDF) View document
Updated protocol

D3820R00006 CSP - PRAC 01212015 final_ppd OK

First published: 22/02/2024
English (335.3 KB - PDF) View document
Study results
Study results

Naloxegol DU Report_Final_V1.0_clean_15July2021_Abstract

English (517.48 KB - PDF) View document
Study report
Other information